Cargando…

A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial

BACKGROUND: Third generation drug-eluting stents (DES) potentially offer better technical performance and reduced neointimal proliferation than previous generation DES. The XLIMIT non-inferiority trial evaluated the performance of the Xlimus (a novel sirolimus-eluting coronary stent system) in terms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Luca, Squillace, Mattia, Ventrella, Nicoletta, Moreno, Raul, Jiménez-Valero, Santiago, Serra, Antoni, Gomez Hospital, Joan Antoni, Bellamoli, Michele, Popolo Rubbio, Antonio, Bedogni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511894/ https://www.ncbi.nlm.nih.gov/pubmed/37745092 http://dx.doi.org/10.3389/fcvm.2023.1199475

Ejemplares similares

XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial
por: Testa, Luca, et al.
Publicado: (2019)

Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction
por: Casenghi, Matteo, et al.
Publicado: (2021)

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
por: Testa, Luca, et al.
Publicado: (2019)

A patient‐specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique
por: De Marco, Federico, et al.
Publicado: (2021)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Subacute Drug-Eluting Stent Thrombosis Caused by Stent Underexpansion: Evaluation by Optical Coherence Tomography
por: Martín-Reyes, Roberto, et al.
Publicado: (2011)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Transcatheter Mitral Valve Repair with the PASCAL System after Early Edge-to-Edge Surgical Failure
por: Granata, Giuseppina, et al.
Publicado: (2021)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021)

A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
por: Abizaid, Alexandre, et al.
Publicado: (2023)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial
por: Kuramitsu, Shoichi, et al.
Publicado: (2016)

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
por: Hamshere, Stephen, et al.
Publicado: (2018)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Optical Coherence Tomography-guided Treatment of Multiple Stent Fracture in Patients with Overlapping Drug-eluting Stents
por: Lee, Jung-Hee, et al.
Publicado: (2018)

Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project
por: Testa, Luca, et al.
Publicado: (2023)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
por: Arroyo, Diego, et al.
Publicado: (2014)

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
por: Romaguera, Rafael, et al.
Publicado: (2021)

Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents()
por: Kilickesmez, Kadriye, et al.
Publicado: (2014)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
por: Yuan, Xiaohang, et al.
Publicado: (2023)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial
por: Gutiérrez-Chico, Juan Luis, et al.
Publicado: (2011)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation
por: Jinnouchi, Hiroyuki, et al.
Publicado: (2021)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
por: Zhu, Ping, et al.
Publicado: (2018)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents
por: Kim, Byeong-Keuk, et al.
Publicado: (2012)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Antibiotic eluting sinus stents
por: Thompson, Harrison M., et al.
Publicado: (2020)

Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial
por: Chae, In-Ho, et al.
Publicado: (2017)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Long‐Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug‐Eluting Stent Implantation
por: Im, Eui, et al.
Publicado: (2019)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_60tog6th3oh6g7a26790a1en9p